Michelle C. Crank

3.7k total citations · 1 hit paper
18 papers, 889 citations indexed

About

Michelle C. Crank is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Michelle C. Crank has authored 18 papers receiving a total of 889 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 6 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Michelle C. Crank's work include Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Cell Function and Interaction (5 papers). Michelle C. Crank is often cited by papers focused on Influenza Virus Research Studies (11 papers), Respiratory viral infections research (9 papers) and Immune Cell Function and Interaction (5 papers). Michelle C. Crank collaborates with scholars based in United States, France and Qatar. Michelle C. Crank's co-authors include Barney S. Graham, John R. Mascola, Gary J. Nabel, Chih‐Jen Wei, John W. Shiver, William E. Paul, Stéphane Caucheteux, Jane Hu‐Li, Shlomo Z. Ben‐Sasson and Xi Chen and has published in prestigious journals such as Nature Communications, The Journal of Experimental Medicine and PLoS ONE.

In The Last Decade

Michelle C. Crank

17 papers receiving 879 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Next-generation influenza vaccines: opportunities and challenges

2020 234 citations Chih‐Jen Wei, Michelle C. Crank et al. Nature Reviews Drug Discovery profile →

Peers

Countries citing papers authored by Michelle C. Crank

Since Specialization

Citations

This map shows the geographic impact of Michelle C. Crank's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle C. Crank with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle C. Crank more than expected).

Fields of papers citing papers by Michelle C. Crank

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle C. Crank. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle C. Crank. The network helps show where Michelle C. Crank may publish in the future.

Co-authorship network of co-authors of Michelle C. Crank

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle C. Crank. A scholar is included among the top collaborators of Michelle C. Crank based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle C. Crank. Michelle C. Crank is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Evaluation of a nanoparticle influenza vaccine in the pig model 2025 ·Vaccine ·Pauline M. van Diemen, Fabian Z. X. Lean, (unknown), Benjamin C. Mollett, Alexander M. P. Byrne, Alejandro Núñez, Eleanor Herbert, Syed M. Moin, Michelle C. Crank, Barney S. Graham, Masaru Kanekiyo, Helen Everett	0
2	Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine 2022 ·Science Translational Medicine ·Emily Phung, Lauren A. Chang, (unknown), Lijuan Yang, (unknown), Scott A. Rush, Kaitlyn M. Morabito, Jason S. McLellan, Ursula J. Buchholz, John R. Mascola, Michelle C. Crank, Grace Chen, Barney S. Graham, Tracy J. Ruckwardt	9
3	CD4 T cell epitope abundance in ferritin core potentiates responses to hemagglutinin nanoparticle vaccines 2022 ·npj Vaccines ·(unknown), Katherine A. Richards, (unknown), Francisco A. Chaves, Michelle C. Crank, Barney S. Graham, Masaru Kanekiyo, Andrea J. Sant	11
4	A prefusion-stabilized RSV F subunit vaccine elicits B cell responses with greater breadth and potency than a postfusion F vaccine 2022 ·Science Translational Medicine ·Lauren A. Chang, Emily Phung, Michelle C. Crank, Kaitlyn M. Morabito, Tonya Villafana, Filip Dubovsky, Judith Falloon, Mark T. Esser, Bob C. Lin, Grace Chen, Barney S. Graham, Tracy J. Ruckwardt	27
5	Broad neutralization of H1 and H3 viruses by adjuvanted influenza HA stem vaccines in nonhuman primates 2021 ·Science Translational Medicine ·Nicole Darricarrère, Yu Qiu, Masaru Kanekiyo, Adrian Creanga, Rebecca A. Gillespie, Syed M. Moin, Jacqueline Saleh, José Sancho, Te-Hui Chou, (unknown), Ruijun Zhang, Shujia Dai, M. Anthony Moody, Kevin O. Saunders, Michelle C. Crank, John R. Mascola, Barney S. Graham, Chih‐Jen Wei, Gary J. Nabel	46
6	A comprehensive influenza reporter virus panel for high-throughput deep profiling of neutralizing antibodies 2021 ·Nature Communications ·Adrian Creanga, Rebecca A. Gillespie, Brian E. Fisher, Sarah F. Andrews, Julia Lederhofer, Christina Yap, (unknown), Tyler Stephens, Yaroslav Tsybovsky, Michelle C. Crank, Julie E. Ledgerwood, Adrian B. McDermott, John R. Mascola, Barney S. Graham, Masaru Kanekiyo	37
7	Author Correction: Next-generation influenza vaccines: opportunities and challenges 2020 ·Nature Reviews Drug Discovery ·Chih‐Jen Wei, Michelle C. Crank, John W. Shiver, Barney S. Graham, John R. Mascola, Gary J. Nabel	9
8	Next-generation influenza vaccines: opportunities and challenges breakdown → 2020 ·Nature Reviews Drug Discovery ·Chih‐Jen Wei, Michelle C. Crank, John W. Shiver, Barney S. Graham, John R. Mascola, Gary J. Nabel	234
9	Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses 2020 ·Nature Communications ·Seyhan Boyoglu-Barnum, Geoffrey B. Hutchinson, Jeffrey C. Boyington, Syed M. Moin, Rebecca A. Gillespie, Yaroslav Tsybovsky, Tyler Stephens, (unknown), Julia Lederhofer, Kizzmekia S. Corbett, Brian E. Fisher, Hadi M. Yassine, Sarah F. Andrews, Michelle C. Crank, Adrian B. McDermott, John R. Mascola, Barney S. Graham, Masaru Kanekiyo	35
10	Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine 2019 ·The Journal of Infectious Diseases ·Michelle C. Crank, John R. Mascola, Barney S. Graham	10
11	Use of Hemagglutinin Stem Probes Demonstrate Prevalence of Broadly Reactive Group 1 Influenza Antibodies in Human Sera 2018 ·Scientific Reports ·Hadi M. Yassine, Patrick M. McTamney, (unknown), Tracy J. Ruckwardt, Michelle C. Crank, Maria K. Smatti, Julie E. Ledgerwood, Barney S. Graham	31
12	An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial 2017 ·npj Vaccines ·Adam DeZure, Emily E. Coates, Zonghui Hu, Galina V. Yamshchikov, Kathryn L. Zephir, Mary E. Enama, Sarah H. Plummer, Ingelise J. Gordon, Florence Kaltovich, (unknown), Adrian B. McDermott, Michelle C. Crank, Richard A. Koup, Richard Schwartz, Robert T. Bailer, Xiangjie Sun, John R. Mascola, Terrence M. Tumpey, Barney S. Graham, Julie E. Ledgerwood	20
13	Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012) 2016 ·PLoS ONE ·Michelle C. Crank, Eleanor Wilson, Laura Novik, Mary E. Enama, Cynthia S. Hendel, Wenjuan Gu, Martha Nason, Robert T. Bailer, Gary J. Nabel, Adrian B. McDermott, John R. Mascola, Richard A. Koup, Julie E. Ledgerwood, Barney S. Graham, (unknown)	10
14	Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults 2015 ·PLoS ONE ·Michelle C. Crank, Ingelise J. Gordon, Galina V. Yamshchikov, Sandra Sitar, Zonghui Hu, Mary E. Enama, LaSonji A. Holman, Robert T. Bailer, Melissa B. Pearce, Richard A. Koup, John R. Mascola, Gary J. Nabel, Terrence M. Tumpey, Richard Schwartz, Barney S. Graham, Julie E. Ledgerwood, (unknown)	20
15	Mutations in PIK3CD Can Cause Hyper IgM Syndrome (HIGM) Associated with Increased Cancer Susceptibility 2014 ·Journal of Clinical Immunology ·Michelle C. Crank, Jennifer Grossman, Susan Moir, Stefania Pittaluga, Clarisa M. Buckner, Lela Kardava, (unknown), H.J. Meuwissen, Jennifer Stoddard, Julie E. Niemela, Hye Sun Kuehn, Sergio D. Rosenzweig	124
16	IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells 2013 ·The Journal of Experimental Medicine ·Shlomo Z. Ben‐Sasson, Alison Hogg, Jane Hu‐Li, Paul T. Wingfield, Xi Chen, Michelle C. Crank, Stéphane Caucheteux, (unknown), Jay A. Berzofsky, Ran Nir‐Paz, William E. Paul	203
17	IL-1 acts on T cells to enhance the magnitude of in vivo immune responses 2011 ·Cytokine ·Shlomo Z. Ben‐Sasson, Stéphane Caucheteux, Michelle C. Crank, Jane Hu‐Li, William E. Paul	45
18	Rituximab but not Other anti-CD20 Antibodies Reverses Multidrug Resistance in 2 B lymphoma Cell Lines, Blocks the Activity of P-glycoprotein (P-gp), and Induces P-gp to Translocate out of Lipid Rafts 2006 ·Journal of Immunotherapy ·Maria-Ana Ghetie, Michelle C. Crank, (unknown), (unknown), Ellen S. Vitetta	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact